Geode Capital Management
FBLG icon

Geode Capital Management’s FibroBiologics FBLG Stock Holding History

Geode Capital Management’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.7K Buy
30,299
+690
+2% +$801 ﹤0.01% 4336
2026
Q1 		$39.1K Buy
29,609
+12,171
+70% +$72.4K ﹤0.01% 4366
2025
Q4 		$78.5K Buy
17,438
+2,991
+21% +$21.1K ﹤0.01% 4152
2025
Q3 		$158K Hold
14,447
– – ﹤0.01% 3999
2025
Q2 		$180K Sell
14,447
-16,285
-53% -$294K ﹤0.01% 3907
2025
Q1 		$553K Buy
30,732
+486
+2% +$13.9K ﹤0.01% 3503
2024
Q4 		$1.21M Buy
30,246
+258
+0.9% +$13.8K ﹤0.01% 3297
2024
Q3 		$1.85M Buy
29,988
+14,202
+90% +$944K ﹤0.01% 3152
2024
Q2 		$1.58M Buy
15,786
+15,237
+2,775% +$2.91M ﹤0.01% 3176
2024
Q1 		$119K Buy
+549
New +$132K ﹤0.01% 4109

Other funds holding FBLG

CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ICM
Islay Capital Management Lubbock, Texas $216M AUM 20.41% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Geode Capital Management's FBLG Position: Q2 2026 in Review

Geode Capital Management increased its FibroBiologics (FBLG) stake by 2.3% in Q2 2026, buying an estimated $801 and bringing the position to 30,299 shares worth $28.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4336.

Geode Capital Management first reported a position in FBLG in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.85M in Q3 2024. 12 funds tracked by Wall St. Rank hold FBLG as of Q2 2026.

  • Geode Capital Management held 30,299 shares of FibroBiologics worth $28.7K as of Q2 2026.
  • Geode Capital Management bought 690 FibroBiologics shares in Q2 2026, an estimated $801.
  • FibroBiologics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4336 holding.
  • Geode Capital Management first reported a position in FibroBiologics in Q1 2024 and has held it in 10 quarters since.
  • Geode Capital Management's FibroBiologics position peaked at $1.85M in Q3 2024.
  • 12 funds tracked by Wall St. Rank held FibroBiologics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.